Francesca Lodato

Summary

Affiliation: University of Bologna
Country: Italy

Publications

  1. ncbi Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence
    Francesca Lodato
    Dipartimento di Medicina Interna e Gastroenterologia, U O di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 12:4253-5. 2006
  2. ncbi Proton pump inhibitors in cirrhosis: tradition or evidence based practice?
    Francesca Lodato
    Dipartimento di Medicina Interna e Gastroenterologia, U O di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 14:2980-5. 2008
  3. ncbi Adverse effects of proton pump inhibitors
    Francesca Lodato
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Best Pract Res Clin Gastroenterol 24:193-201. 2010
  4. ncbi G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence
    Francesca Lodato
    Department of Digestive Diseases and Internal Medicine, University of Bologna, Bologna 40138, Italy
    World J Gastroenterol 15:5449-54. 2009
  5. ncbi Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations
    Francesca Lodato
    Dipartimento di Medicina Interna e Gastroenterologia, UO di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 12:7239-49. 2006
  6. ncbi Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases
    Davide Festi
    Department of Internal Medicine and Gastroenterology, Policlinico S Orsola Malpighi, Bologna, Italy
    Curr Clin Pharmacol 2:155-77. 2007
  7. ncbi Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agent
    Francesca Lodato
    Department of Internal Medicine and Gastroenterology, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
    Liver Transpl 12:1711-4. 2006
  8. ncbi Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience
    Francesca Lodato
    Department of Digestive Diseases and Internal Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Scand J Gastroenterol 47:1494-500. 2012
  9. ncbi Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study
    Maurizio Biselli
    Department of Clinical Medicine, University of Bologna, Azienda Ospedaliero Universitaria, Policlinico S Orsola Malpighi, Bologna, Italy
    J Clin Gastroenterol 44:52-7. 2010
  10. ncbi Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis
    Francesco Azzaroli
    Department of Internal Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna
    World J Gastroenterol 10:3099-102. 2004

Collaborators

Detail Information

Publications11

  1. ncbi Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence
    Francesca Lodato
    Dipartimento di Medicina Interna e Gastroenterologia, U O di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 12:4253-5. 2006
    ....
  2. ncbi Proton pump inhibitors in cirrhosis: tradition or evidence based practice?
    Francesca Lodato
    Dipartimento di Medicina Interna e Gastroenterologia, U O di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 14:2980-5. 2008
    ..In conclusion, the use of this class of drugs seems more habit related than evidence-based eventually leading to an increase in health costs...
  3. ncbi Adverse effects of proton pump inhibitors
    Francesca Lodato
    Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
    Best Pract Res Clin Gastroenterol 24:193-201. 2010
    ..In fact, in clinical practise, PPI are often prescribed in patients without a specific acid related disease and continued long term based on their safety profile. This review focus on the main adverse events related to long term PPI use...
  4. ncbi G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence
    Francesca Lodato
    Department of Digestive Diseases and Internal Medicine, University of Bologna, Bologna 40138, Italy
    World J Gastroenterol 15:5449-54. 2009
    ....
  5. ncbi Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations
    Francesca Lodato
    Dipartimento di Medicina Interna e Gastroenterologia, UO di Gastroenterologia, Via Massarenti 9, Bologna 40138, Italy
    World J Gastroenterol 12:7239-49. 2006
    ..Thus the real contribution of medical treatment to HCC prevention in patients with chronic viral hepatitis is small. Great efforts are needed to identify more effective medical measures for primary and secondary prevention of HCC...
  6. ncbi Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases
    Davide Festi
    Department of Internal Medicine and Gastroenterology, Policlinico S Orsola Malpighi, Bologna, Italy
    Curr Clin Pharmacol 2:155-77. 2007
    ..The future availability of UDCA derivatives will possibly enhance the chances to effectively treat chronic cholestatic diseases...
  7. ncbi Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agent
    Francesca Lodato
    Department of Internal Medicine and Gastroenterology, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
    Liver Transpl 12:1711-4. 2006
    ..They may cause both localized and disseminated infection. In conclusion, Fusarium spp. etiology should be considered in the context of infectious diseases following liver transplantation...
  8. ncbi Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience
    Francesca Lodato
    Department of Digestive Diseases and Internal Medicine, S Orsola Malpighi University Hospital, Bologna, Italy
    Scand J Gastroenterol 47:1494-500. 2012
    ..Different models have been proposed for the prediction of survival after TIPS. The aim of this study was to evaluate the predictive factors associated with patients' survival after TIPS placement for refractory ascites...
  9. ncbi Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study
    Maurizio Biselli
    Department of Clinical Medicine, University of Bologna, Azienda Ospedaliero Universitaria, Policlinico S Orsola Malpighi, Bologna, Italy
    J Clin Gastroenterol 44:52-7. 2010
    ..Alcoholic liver cirrhosis (ALC) is a leading indication for orthotopic liver transplantation (OLT)...
  10. ncbi Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis
    Francesco Azzaroli
    Department of Internal Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna
    World J Gastroenterol 10:3099-102. 2004
    ..Data on the preventive effect of IFN plus ribavirin treatment are lacking...
  11. ncbi Surveillance and diagnosis for hepatocellular carcinoma
    M Rasool Aljabiri
    The Sheila Sherlock Hepatobiliary-Pancreatic and Liver Transplantation Unit, The Royal Free Hospital, Hampstead, London, UK
    Liver Transpl 13:S2-12. 2007